company background image
MDKA

Medika d.dZGSE:MDKA Stock Report

Market Cap

Kn752.8m

7D

0%

1Y

52.9%

Updated

23 Sep, 2021

Data

Company Financials
MDKA fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends3/6

MDKA Overview

Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia.

Price History & Performance

Summary of all time highs, changes and price drops for Medika d.d
Historical stock prices
Current Share PriceKn26,000.00
52 Week HighKn16,000.00
52 Week LowKn26,400.00
Beta0.24
1 Month Change13.04%
3 Month Change23.81%
1 Year Change52.94%
3 Year Change61.49%
5 Year Change62.50%
Change since IPO229.11%

Recent News & Updates

Jul 29
Statutory Profit Doesn't Reflect How Good Medika d.d's (ZGSE:MDKA) Earnings Are

Statutory Profit Doesn't Reflect How Good Medika d.d's (ZGSE:MDKA) Earnings Are

The subdued stock price reaction suggests that Medika d.d.'s ( ZGSE:MDKA ) strong earnings didn't offer any surprises...

Shareholder Returns

MDKAHR HealthcareHR Market
7D0%1.6%0.6%
1Y52.9%13.1%15.8%

Return vs Industry: MDKA exceeded the HR Healthcare industry which returned 13.2% over the past year.

Return vs Market: MDKA exceeded the HR Market which returned 14.3% over the past year.

Price Volatility

Is MDKA's price volatile compared to industry and market?
MDKA volatility
MDKA Beta0.24
Industry Beta0.98
Market Beta1

Stable Share Price: Insufficient data to determine MDKA's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine MDKA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1922920Jasminko Herceghttps://www.medika.hr

Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. The company primarily sells, stores, and distributes human and veterinary drugs, medicinal products, equipment and dental supplies, dietetic, cosmetic, hygienic, and other products. It serves pharmacies, healthcare facilities, hospitals, health centers, outpatient facilities, doctor’s offices, wholesalers, and specialized stores; and dental practices, veterinary clinics, and medical centers, as well as other customers, including herbal pharmacies, companies, optics, and other.

Medika d.d Fundamentals Summary

How do Medika d.d's earnings and revenue compare to its market cap?
MDKA fundamental statistics
Market CapKn752.80m
Earnings (TTM)Kn92.41m
Revenue (TTM)Kn3.99b

8.1x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MDKA income statement (TTM)
RevenueKn3.99b
Cost of RevenueKn3.67b
Gross ProfitKn320.31m
ExpensesKn227.90m
EarningsKn92.41m

Dividends

5.4%

Current Dividend Yield

44%

Payout Ratio

Valuation

Is Medika d.d undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MDKA (HRK26000) is trading below our estimate of fair value (HRK891451.29)

Significantly Below Fair Value: MDKA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MDKA is good value based on its PE Ratio (8.1x) compared to the European Healthcare industry average (25.3x).

PE vs Market: MDKA is good value based on its PE Ratio (8.1x) compared to the HR market (16.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MDKA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MDKA is good value based on its PB Ratio (1.3x) compared to the XE Healthcare industry average (2.3x).


Future Growth

How is Medika d.d forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medika d.d has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Medika d.d performed over the past 5 years?

9.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MDKA has high quality earnings.

Growing Profit Margin: MDKA's current net profit margins (2.3%) are higher than last year (1.7%).


Past Earnings Growth Analysis

Earnings Trend: MDKA's earnings have grown by 9.6% per year over the past 5 years.

Accelerating Growth: MDKA's earnings growth over the past year (42.2%) exceeds its 5-year average (9.6% per year).

Earnings vs Industry: MDKA earnings growth over the past year (42.2%) exceeded the Healthcare industry 31.2%.


Return on Equity

High ROE: MDKA's Return on Equity (15.8%) is considered low.


Financial Health

How is Medika d.d's financial position?


Financial Position Analysis

Short Term Liabilities: MDKA's short term assets (HRK1.9B) exceed its short term liabilities (HRK1.8B).

Long Term Liabilities: MDKA's short term assets (HRK1.9B) exceed its long term liabilities (HRK125.5M).


Debt to Equity History and Analysis

Debt Level: MDKA's debt to equity ratio (43.5%) is considered high.

Reducing Debt: MDKA's debt to equity ratio has reduced from 94.1% to 43.5% over the past 5 years.

Debt Coverage: MDKA's debt is well covered by operating cash flow (143.4%).

Interest Coverage: MDKA's interest payments on its debt are well covered by EBIT (89.9x coverage).


Balance Sheet


Dividend

What is Medika d.d current dividend yield, its reliability and sustainability?

5.38%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MDKA's dividend (5.38%) is higher than the bottom 25% of dividend payers in the HR market (1.84%).

High Dividend: MDKA's dividend (5.38%) is in the top 25% of dividend payers in the HR market (4.12%)


Stability and Growth of Payments

Stable Dividend: MDKA has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: MDKA's dividend payments have increased, but the company has only paid a dividend for 9 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (43.9%), MDKA's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average board tenure


CEO

Jasminko Herceg

no data

Tenure

Mr. Jasminko Herceg, Dipl. Oec, serves as a President of Management Board at Medika, d.d


Board Members

Experienced Board: MDKA's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.2%.


Top Shareholders

Company Information

Medika d.d.'s employee growth, exchange listings and data sources


Key Information

  • Name: Medika d.d.
  • Ticker: MDKA
  • Exchange: ZGSE
  • Founded: 1922
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: Kn752.804m
  • Shares outstanding: 28.95k
  • Website: https://www.medika.hr

Number of Employees


Location

  • Medika d.d.
  • Capraska 1
  • Zagreb
  • 10000
  • Croatia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/23 16:07
End of Day Share Price2021/09/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.